Agenesis of internal carotid artery associated with isolated growth hormone deficiency: A case report and literature review by Stagi, Stefano et al.
CASE REPORT Open Access
Agenesis of internal carotid artery associated
with isolated growth hormone deficiency: a
case report and literature review
Stefano Stagi1*, Giovanna Traficante2, Elisabetta Lapi2, Marilena Pantaleo2, Sabrina Becciani1, Marzia Mortilla3,
Salvatore Seminara1 and Maurizio de Martino1
Abstract
Background: Agenesis of the internal carotid artery (ICA) is a rare congenital abnormality, sporadically reported to
be associated with a combined congenital hypopituitarism. Nevertheless, only a few cases have been extensively
described, and none of these have been characterized by an isolated growth hormone (GH) deficiency.
Case presentation: Here, we describe a 17-year old boy referred to our hospital for fatigue, decreased muscle
strength and severe headache reported after the cessation of rhGH treatment for a GH deficiency diagnosed at the
age of 2 years and 3 months. Magnetic resonance imaging (MRI) showed an adenohypophyseal hypoplasia with a
lack of posterior pituitary hyperintensity, whereas MRI angiography indicated the absence of a normal flow void in
the left ICA. Endocrinological tests confirmed the GH deficiency (GH peak after growth-hormone-releasing hormone
(GHRH) + arginine: 2.42 ng/mL) with a very low IGF-I value (31 ng/mL) and normal function of other pituitary axes.
Conclusion: To the best of our knowledge this is the first confirmed case of an isolated GH deficiency in a patient
with ICA agenesis. The presence of an isolated pituitary deficit is unlike to be considered only as an effect of
hemodynamic mechanism, suggesting a role for genetic factor(s) as a common cause of these two rare birth
defects. Further studies could clarify this issue and the underlying mechanisms to better understand the
etiopathogenetic characteristics of this disorder.
Background
Agenesis, aplasia and hypoplasia of the internal carotid
artery (ICA) are rare congenital vascular malformations
[1]. Of these, agenesis of the ICA is an extremely rare
vascular anomaly occurring in less than 0.01 % of the
population [2]. A 3:1 left side predominance in the ICA
agenesis has been reported [1].
Agenesis of the ICA is rarely associated with congeni-
tal hypopituitarism (CH) [3]. CH is also a very rare con-
genital manifestation presenting either as an isolated
hormone deficiency—the most common of which is iso-
lated growth hormone deficiency (IGHD)—or multiple
pituitary hormone involvement (combined pituitary hor-
mone deficiencies (CPHD)) [4].
The etiology of this association is not clear: even if the
blocking of a unilateral blood supply might cause the pi-
tuitary hypoplasia, a possible genetic cause, such as com-
plex neural crest differentiation and/or migration
disorders, cannot be excluded.
To the best of our knowledge, no more than 12 cases of
CPHD associated with ICA have been reported [2, 5–14]
(Table 1). However, a case of transient IGHD has been
also described even though it may be caused by a reduced
flow because of a focal stenosis in the right distal internal
carotid artery and right middle cerebral artery due to a
moyamoya [15]. Given the rarity of these two conditions,
the association is unlikely to be causal, although this pos-
sibility cannot be excluded. In this report, we describe for
the first time a 17-year-old boy with a confirmed diagnosis
of IGHD and we review the literature and discuss the eti-
ology of this association.
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Case report
The patient was a 17-year-old boy on rhGH therapy for
14 years because of a GH deficiency that was diagnosed
at the age of 2 years and 3 months. Therapy was stopped
9 months before the beginning of symptoms—fatigue,
decreased muscle strength and severe headache. How-
ever, the patient had not come for retesting one month
after discontinuation of rhGH treatment.
The propositus was the first child of non-consanguineous
Italian parents. The mother was in treatment for post-
partum depression. The maternal grandfather was in treat-
ment for autoimmune hyperthyroidism.
The mother’s height was 152 cm and she had menar-
che at the age of 13; the father’s height was 168 cm and
he had a normal development. The target height was
166.0 ± 6.0 cm (−1.70 SDS). All auxological data were
normalized for chronological age by conversion to
standard deviation scores (SDS) that were calculated ac-
cording to the following formula: patient value - mean
of age-related reference value/standard deviation of the
age-related reference value [16].
The child was born at 40 weeks of gestation with an
uncomplicated delivery. The birth weight was 2970 g
(−1.15 SDS), length at birth was 50 cm (−0.30 SDS), and
his occipito-frontal head circumference (OFC) was
34 cm (−0.61 SDS). He had neonatal jaundice requiring
phototherapy. The child’s neuromotor development was
normal: he sat at 6 months, walked independently at
12 months, and began to use language at 14 months.
At 6 months, the patient exhibited very deficient
growth (Fig. 1a and b). At 2 years and 3 months, he was
admitted to our Paediatric Endocrine Unit for an endo-
crinological evaluation. His height, evaluated according
the growth charts compiled by Cacciari et al. [17], was
78.6 cm (−2.79 SDS). His weight was 9.830 kg (−2.78
SDS), and his BMI was 15.91 (−0.28 SDS) (Fig. 1a-d).
Extensive biochemical, endocrinological and metabolic
examinations did not reveal any abnormalities with the
exception of plasma concentrations of IGF-I and IGFBP-
3 that were low for his age and sex: 27 ng/mL and
1.38 μg/mL, respectively. Thus, GH stimulation tests
were performed and showed a reduced response after
the clonidine (GH peak of 5.2 ng/mL) and insulin (glu-
cose nadir 2.0 mmol/L at 30 min; GH peak of 3.9 ng/
mL) tests. This revealed a GH deficiency (GHD). Bone
age was assessed according to the Greulich and Pyle
method [18], and it was delayed (1 year and 2 months
versus a chronological age of 2 years and 3 months).
Brain MRI of the hypophyseal region showed the pres-
ence of a pituitary hypoplasia (height 1.8 mm and width
2.7 mm). Consequently, hGH therapy (0.22 mg/kg/wk)
was started.
The child responded very well to rhGH treatment
(Fig. 1c) and at 3 years and 4 months old, his height was
94.5 cm (−1.14 SDS), weight 12.450 kg (−2.10 SDS),
height velocity 15.06 cm/yr (5.05 SDS), and BMI 13.94
(−1.75 SDS). At 4 years and 3 months old, his height
was 101.9 cm (−0.82 SDS), his weight was 15.300 kg
(−1.24 SDS), his height velocity was 8.05 cm/yr (1.12
SDS), and his BMI was 14.73 (−0.82 SDS).
The onset of puberty occurred at 12 years old with
normal onset, timing, tempo, and magnitude of pubertal
changes [19]. He stopped rhGH treatment at 16 years
and 3 months old when he reached the definitive stature
[16]: his height was 170.8 cm (−0.64 SDS) and his weight
was 51.800 kg (−1.56 SDS) with a BMI of 17.76 (−1.63
SDS) (Fig. 1c and d).
At 17 years old, his GH secretion was re-tested by the
growth-hormone-releasing hormone (GHRH) + arginine
test, which is a reliable test of ITT in retesting patients
who had undergone GH treatment in childhood [20].
The test confirmed a severe GH deficiency (basal GH
value of 0.18 ng/mL; GH peak of 2.42 ng/mL).
MRI angiography was performed because of the severe
growth hormone deficiency (GHD) and headache; it
confirmed the presence of adenohypophyseal hypoplasia
(height 2.5 mm and width 3.5 mm) with a lack of poster-
ior pituitary hyperintensity. The MRI angiography also
showed the absence of a normal flow void in the left
ICA (Fig. 2).
No abnormal findings were noted in the electrocardio-
gram. Chromosomal studies of the peripheral lympho-
cyte cultures revealed a 46,XY normal male karyotype.
An array of CGH analyses on the patient’s DNA was
performed with an Agilent 60 K array platform with a
resolution of approximately 100 kb. No genomic imbal-
ances were detected. A complete examination was
performed with particular attention to neurology, metab-
olism, and endocrinology (Table 2). The only abnormal
result was a very low IGF-I value (31 ng/mL). In light of
these results, the patient restarted rhGH therapy, and
his symptoms at the time of referral disappeared.
Discussion
ICA agenesis is a rare congenital abnormality that is very
rarely associated with CH. All reported cases refer to pa-
tients with CPHD and ICA agenesis although many of
these reports did not describe—or only poorly descri-
bed—the possible associated endocrinological abnormal-
ities and treatments. This had led many to hypothesize a
vascular cause of pituitary disorders. Two different the-
ories involving the hemodynamic mechanisms or disor-
ders of differentiation and/or migration of the neural
crest have been reported [2].
The ICA originates from the third aortic arch during
embryogenesis. However, it is controversial whether the
common and external carotids really originate from the
same third aortic arch or from the aortic sac [21]. In
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patients presenting a vascular anomaly of the ICA, the
blood supply of the affected side is partially or completely
compensated by the vertebrobasilar or contralateral ICA
system. This is characterized by the enlargement of a nor-
mally existing segment or presence of abnormal or persist-
ing fetal arteries [22]. In most patients, this vascular
anomaly is asymptomatic [23], and the rarity of a pediatric
ICA agenesis diagnosis suggests that the arterial collat-
eral pathways are initially sufficient to support cerebral
perfusion [24]. However, some patients may experience
recurrent headaches, blurred vision, hemiparesis, and
hypopituitarism [25, 26] likely due to cerebrovascular in-
sufficiency, compression by collateral vessels, or associated
cerebral aneurysms [21]. Moreover, the symptoms
Table 1 Review of endocrinological and anatomical characteristics of patients with congenital hypopituitarism and internal carotid
malformations
Sex Age Pituitary MRI Internal carotid RMI Other characteristics Molecular
studies
References
1 N N Not specified (except
for normal posterior pituitary).
Absence of ICA and carotid
canal.
Not specified. NP [14]
2 M 18 m Pituitary hypoplasia. Anomaly of right ICA. TSH, GH, ACTH deficiency. Central
diabetes insipidus. Possible
hypogonadism.
NP [13]
3 F 5 m Absence of anterior pituitary
and ectopic pituitary
posterior lobe.
Absence of right common carotid
artery, right ICA, right anterior
cerebral artery.
TSH, ACTH and GH deficiency. No
evidence of diabetes insipidus. Genitalia
were normal. Single central maxillary
incisor.
NP [7]
4 M 23 year Absence of anterior pituitary
and ectopic pituitary
posterior lobe.
Absence of right ICA and carotid
canal and A1 segment of the right
anterior cerebral artery.
Congenital microphthalmia with
cataract and coloboma of the right eye,
encephalocele. Hormonal substitution
treatments not specified.
NP [5]
5 M 37 year Absence of anterior pituitary. Hypoplasia of right ICA and
carotid canal.
Amblyopia of the left eye caused by an
optic nerve coloboma, encephalocele.
Hormonal substitution treatments not
specified.
NP [5]
6 F 29 year Pituitary hypoplasia and
ectopic pituitary posterior
lobe.
Absence of right ICA, carotid canal,
and A1 segment of the right
anterior cerebral artery.
TSH, ACTH, and GH deficiency. No
evidence of diabetes insipidus.
Hypogonadism. Chiari I malformation
with syringomyelia.
NP [9]
7 M 5 year Absence of anterior pituitary
and ectopic pituitary
posterior lobe.
Absence of left ICA and carotid
canal, A1 segment of the left
anterior cerebral artery and the
anterior communicating artery.
Retrognathia, microphallus, and
cryptorchidism. TSH, ACTH, GH
deficiency, but no evidence of diabetes
insipidus. Possibile hypogonadism.
NP [10]
8 M 11 year Pituitary hypoplasia Absence of left ICA and carotid
canal; hypoplasia of A1 segment of
left anterior cerebral artery
TSH, ACTH, GH deficiency. Central
diabetes insipidus. Microphallus with
possible hypogonadism.
NP [6]
9 F 10 year Hypoplastic anterior pituitary,
flat sella turcica, absent
pituitary stalk
Agenesis of the left ICA and the
left carotid canal
GH, TSH, gonadotropin deficiency. No
evidence of diabetes insipidus. Born out
of a consanguineous marriage.
No
HESX1,
LHX4,
OTX2
mutations
[8]
10 F 7
month
Adenohypophyseal
hypoplasia with a lack of
posterior pituitary
hyperintensity
Absence of the left ICA Desaturation episodes, recurrent
respiratory infections. Short hands and
feet. GH, ACTH and TSH deficiency.
17q24.2
deletion
[3]
11 F 2 year Adenohypophyseal
hypoplasia with a lack of
posterior pituitary
hyperintensity
Absence of the right ICA GH, TSH, and gonadotropin deficiency.
No clinical evidence of diabetes
insipidus.
NP [11]
12 M 3 week Absence of anterior pituitary
with ectopic posterior
pituitary
Absence of the left ICA and
carotid canal
GH, TSH, ACTH and gonadotropin
deficiency. Microphallus.
NP [12]
13 M 17 year Adenohypophyseal
hypoplasia with a lack of
posterior pituitary
hyperintensity
Agenesis of the left ICA GH deficiency. No other pituitary
deficiencies. No clinical evidence of
diabetes insipidus.
Normal
array-CGH
Our case
NP not performed
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Fig. 1 Length (a), weight (b), height (c) and body mass index (BMI; d) growth charts of the patient. The growth charts of the length and weight
refer to the first 3 years 4 months of life. The arrows indicate the age at which growth hormone treatment was initiated (black arrow). The length
and the weight were evaluated according the growth charts compiled by de Onis et al. [37]. The height and BMI were evaluated according the
growth charts compiled by Cacciari et al. [17]
Fig. 2 A MRI angiography time-of-flight (TOF) three-dimensional (3D) technique through the circle of Willis revealed agenesis of the intracranial
portion of the left internal carotid artery (ICA). a. 3D TOF in the axial plane at the carotid siphon level shows agenesis of the left ICA. b. 3D TOF in
the axial plane for the vertebrobasilar system shows the left vertebral artery and the compensatory hypertrophy. c. MRI angiography maximum intensity
projection (MIP) reconstruction in the axial plane reveals agenesis of the intracranial portion of the left ICA. d. MRI angiography MIP reconstruction in
the coronal plane highlights hypertrophy in the left vertebral collateral blood flow. e. Sagittal T1W TSE sequence shows adenohypophyseal hypoplasia
(height 2.5 mm and width 3.5 mm) with a lack of posterior pituitary hyperintensity
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reported by our patient were probably the result of both
GHD (fatigue, decreased muscle strength, etc.) and ICA
agenesis (headache).
Only one of the 13 patients previously described in the
literature had MRI evidence of associated vascular de-
fects. This patient had transient GH deficiency and was
described by Quah et al. [15]. This patient’s pituitary de-
fects and neurological symptoms may have been caused
by reduced flow due to a focal stenosis of the other dis-
tal internal carotid artery and right middle cerebral ar-
tery due to a moyamoya [15]. However, the presence of
a defect in the vascular perfusion is difficult to reconcile
with the pituitary anatomical abnormalities and with the
variability of the endocrinological defects reported in-
cluding isolated GH deficiency or central diabetes insipi-
dus (described only rarely) [6, 15].
The ICA is formed in embryos during the fourth week
from the third aortic arch arteries and during the fifth
and sixth weeks from the terminal segments of the dor-
sal aorta [27]. Conversely, the pituitary gland fully de-
velops due to merging of the Rathke pouch and the
infundibulum by the eighth week of gestation. The blood
supply of the anterior and posterior pituitary gland
comes from the bilateral superior and inferior hypophys-
eal arteries arising from the ICA [28]. It is not clear why
pituitary hypoplasia would result from blocking of a uni-
lateral blood supply and from abnormalities of the hypo-
physeal anatomy such as adenohypophysis hypoplasia
and aplasia. However, the presence of ectopic neurophy-
pophysis, which has been described in some patients, or
other hypophyseal abnormalities, may also suggest a
genetic etiology.
Pituitary gland development and function depend on
the sequential temporal and spatial expression of mul-
tiple transcription factor genes such as POU1F1 (POU
class 1 homeobox 1; OMIM 173110), PROP1 (prophet of
PIT1; OMIM 601538), HESX1 (homeobox gene expressed
in ES cells; OMIM 601802), LHX3 (LIM homeobox gene
3; OMIM 600577), LHX4 (LIM homeobox gene 4; OMIM
602146), SOX3 (SRY-related HMG-box gene 3; OMIM
313430), and OTX2 (orthodenticle homolog 2; OMIM
600037) [4]. However, these defects may cause a defi-
ciency in one or more pituitary hormones. Its clinical
features vary in both severity and time of presentation,
and onset may occur in the neonatal period or develop
later in life [29–31]. In some patients, the hormonal
deficiencies may present as a part of a syndrome with
patients manifesting abnormalities in structures that
share a common embryological origin with the pituitary
gland [29–31].
In our review 6 patients, in addition to our, had a
pituitary hypoplasia [3, 6, 8, 9, 11, 13]. This abnormality
was isolated in two cases [6, 13], associated with
ectopic neurohypophysis [9], absent pituitary stalk [8], or
associated with a lack of posterior pituitary hyperintensity
[3, 11]. However 5 patients had an absent adenohypophy-
sis [5, 7, 10, 12] and 4 associated of these showed an
ectopic neurohypophysis [5, 7, 10, 12].
Moreover, ectopic neurohypophysis may be accompan-
ied by midline brain defects [32] supporting an embryo-
logical defect due to genetic factors [32, 33]. This has
been reported in idiopathic GH deficiency or in subjects
with HESX1, LHX4, and SOX3 gene mutations [34]. For
example, both the SOX3 under- and over-expression
may result in CPHD or IGHD in males, associated with
infundibular hypoplasia, ectopic/undescended posterior
pituitary, and abnormalities of the corpus callosum
[35]. In these patients, congenital abnormalities of the
ICA or other vessels have not been reported [35]. How-
ever, the associated midline anomalies (coloboma,
single central maxillary tooth, transsphenoidal encepha-
locele, and Chiari I malformation) reported in some
cases [5, 7, 9, 15] may support this hypothesis.
Of the patients in our review, one case had unilateral
agenesis of the internal carotid artery associated with
CPHD without HESX1, LHX4, or OTX2 mutations [8].
Moreover, Savasta et al. [3] recently reported a CNV
(copy number variant) i.e. a paternally inherited 200-kb
deletion in 17q24.2. Thus, we performed array-CGH in
our patient, but discovered no genomic imbalances.
However, we indicate the need for further molecular
analysis by NGS techniques to discover possible molecu-
lar abnormalities associated with this syndrome.
Given the rarity of the two conditions, the association
is unlikely to be causal, although this cannot be excluded
[36]. So, we hypothesize that an unknown gene mutation
Table 2 Laboratory results at left ICA agenesis diagnosis
Value Reference values Value Reference values
FreeT4, pmol/L 12.4 10.3–19.4 HbA1c, % 4.4 <5.5
TSH, mIU/L 1.20 0.40–4.0 Na+, mEq/L 138 135–145
Cortisol, μg/dL 16.8 5.0–19.0 K+, mEq/L 4.2 3.5–5.0
ACTH, ng/L 25.7 9.0–52.0 Cl−, mEq/L 101 95–105
Prolactin, mIU/L 271 87.0–392.0 Plasma osmolality, mOsm/kg 295 280–300
Total testosterone, ng/mL 378 270.0–1070.0 Urine Osmolality, mOsm/kg 1037 400–1100
TSH thyroid-stimulating hormone, ACTH adrenocorticotrophic hormone
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is the most likely explanation for the anatomical defects
seen in these patients, suggesting a role for genetic
factor(s) as a common cause of these two birth defects.
Conclusions
Here were report the first case of a confirmed isolated
GH deficiency in a patient with ICA agenesis. Our
experience suggests the opportunity to carefully evaluate
possible vascular abnormalities in case of IGHD or
CPHD. The presence of an isolated pituitary deficit, and
the rare association between the two conditions, suggest a
genetic rather than a hemodynamic mechanism. Further
studies, especially with NGS-based molecular analysis,
could clarify this issue and the underlying mechanisms to
better understand the etiopathogenetic characteristics of
this disorder.
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